Physician profile
Audrey E Lands
NPI 1528603511
$8,068.98
in general payments reported to CMS, 2019-2025
53 companies · $1,849 in 2025
The $1,849 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $989 · 2022: $1,536 · 2023: $1,551 · 2024: $2,144 · 2025: $1,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,524 · Entertainment: $17.89 · Education: $1.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,524.18 |
| Entertainment | $17.89 |
| Education | $1.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,460.76 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $733.05 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $610.13 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $591.97 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $588.85 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $402.20 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $294.52 | 2021-2024 | |
| Pfizer INC. | $293.17 | 2022-2025 | |
| Glaxosmithkline, LLC. | $290.75 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Mylan Specialty L.P. | $259.20 | 2021-2024 | Yupelri |
| Eisai INC. | $210.04 | 2024-2025 | |
| Amgen INC. | $185.06 | 2022-2025 | Krystexxa, Otezla, Repatha |
| Viatris Specialty LLC | $153.71 | 2025 | Yupelri |
| Vanda Pharmaceuticals INC. | $153.60 | 2021-2025 | Hetlioz, Fanapt |
| Edwards Lifesciences Corporation | $147.01 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $143.66 | 2022-2025 | Dexcom G6 Transmitter |
| Lucid Diagnostics INC. | $116.34 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $110.29 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $110.27 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.02 | 2024 | Lifevest |
| Boston Scientific Corporation | $91.13 | 2021-2025 | General - Vascular Intervention |
| Corcept Therapeutics | $81.06 | 2022-2024 | Korlym |
| Kowa Pharmaceuticals America, INC. | $66.47 | 2022-2024 | Livalo, Seglentis |
| Xeris Pharmaceuticals, INC. | $65.37 | 2023 | Gvoke Hypopen |
| Phadia US INC. | $64.93 | 2021-2024 | Immunocap |
| Nestle Healthcare Nutrition INC. | $63.82 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $54.22 | 2022-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Astellas Pharma US INC | $51.69 | 2024-2025 | Veozah |
| Braeburn INC. | $45.65 | 2023-2024 | Brixadi |
| Abbott Laboratories | $44.40 | 2023-2025 | Freestyle Libre 3, Proclaim |
| Idorsia Pharmaceuticals US INC | $35.41 | 2022-2023 | Quviviq |
| Sanofi Pasteur INC. | $32.99 | 2023 | |
| Ironwood Pharmaceuticals, INC | $32.86 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.36 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $26.90 | 2025 | Zenpep |
| Renalytix Ai, INC. | $26.59 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Alexion Pharmaceuticals, INC. | $26.25 | 2022 | |
| Pharmacosmos Therapeutics INC. | $24.82 | 2022 | |
| Sumitomo Pharma America, INC. | $21.27 | 2025 | Gemtesa |
| Angiodynamics, INC. | $20.07 | 2025 | Auryon Laser System 100-120 Vac |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.97 | 2022 | |
| Optos, INC. | $17.89 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Esperion Therapeutics, INC. | $17.61 | 2021 | |
| Exact Sciences Corporation | $17.34 | 2024 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $17.25 | 2021 | |
| Indivior INC. | $17.20 | 2022 | |
| Inspire Medical Systems, INC. | $17.20 | 2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $16.77 | 2021 | |
| Amarin Pharma, INC. | $16.60 | 2022 | |
| Ascensia Diabetes Care US INC. | $14.81 | 2024 | |
| Medtronic, INC. | $13.80 | 2022 | |
| Nevro Corp. | $12.92 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Lands listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.